These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 22788914)

  • 21. Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis.
    Kiani AN; Johnson K; Chen C; Diehl E; Hu H; Vasudevan G; Singh S; Magder LS; Knechtle SJ; Petri M
    J Rheumatol; 2009 Oct; 36(10):2224-30. PubMed ID: 19648301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
    Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
    Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urine Galectin-3 binding protein reflects nephritis activity in systemic lupus erythematosus.
    Faustini F; Idborg H; Fuzzi E; Larsson A; Lie WR; Pötzsch S; Okitsu SL; Svenungsson E; Gunnarsson I
    Lupus; 2023 Feb; 32(2):252-262. PubMed ID: 36508734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive aptamer-based screening identifies a spectrum of urinary biomarkers of lupus nephritis across ethnicities.
    Stanley S; Vanarsa K; Soliman S; Habazi D; Pedroza C; Gidley G; Zhang T; Mohan S; Der E; Suryawanshi H; Tuschl T; Buyon J; Putterman C; Mok CC; Petri M; Saxena R; Mohan C
    Nat Commun; 2020 May; 11(1):2197. PubMed ID: 32366845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective validation of a novel renal activity index of lupus nephritis.
    Gulati G; Bennett MR; Abulaban K; Song H; Zhang X; Ma Q; Brodsky SV; Nadasdy T; Haffner C; Wiley K; Ardoin SP; Devarajan P; Ying J; Rovin BH; Brunner HI
    Lupus; 2017 Aug; 26(9):927-936. PubMed ID: 28361601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Composite urinary biomarkers to predict pathological tubulointerstitial lesions in lupus nephritis.
    Ding Y; Nie LM; Pang Y; Wu WJ; Tan Y; Yu F; Zhao MH
    Lupus; 2018 Oct; 27(11):1778-1789. PubMed ID: 30020021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of chemokine and fibrosing factor messenger RNA in the urinary sediment of patients with lupus nephritis.
    Chan RW; Lai FM; Li EK; Tam LS; Wong TY; Szeto CY; Li PK; Szeto CC
    Arthritis Rheum; 2004 Sep; 50(9):2882-90. PubMed ID: 15457456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Urine sCD163 With Proliferative Lupus Nephritis, Fibrinoid Necrosis, Cellular Crescents and Intrarenal M2 Macrophages.
    Zhang T; Li H; Vanarsa K; Gidley G; Mok CC; Petri M; Saxena R; Mohan C
    Front Immunol; 2020; 11():671. PubMed ID: 32351512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative analysis of neutrophil gelatinase-associated lipocalin and other laboratory markers for lupus nephritis: a cross-sectional investigation.
    La'ulu SL; Suh-Lailam BB; Davis KW; Straseski JA; Tebo AE
    Ann Clin Biochem; 2017 Mar; 54(2):240-245. PubMed ID: 27166308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring urine:serum fractional excretion ratios as potential biomarkers for lupus nephritis.
    Soliman SA; Stanley S; Vanarsa K; Ismail F; Mok CC; Mohan C
    Front Immunol; 2022; 13():910993. PubMed ID: 36091001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deep Phenotyping of Urinary Leukocytes by Mass Cytometry Reveals a Leukocyte Signature for Early and Non-Invasive Prediction of Response to Treatment in Active Lupus Nephritis.
    Bertolo M; Baumgart S; Durek P; Peddinghaus A; Mei H; Rose T; Enghard P; Grützkau A
    Front Immunol; 2020; 11():256. PubMed ID: 32265898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary CD163 is a marker of active kidney disease in childhood-onset lupus nephritis.
    Inthavong H; Vanarsa K; Castillo J; Hicks MJ; Mohan C; Wenderfer SE
    Rheumatology (Oxford); 2023 Mar; 62(3):1335-1342. PubMed ID: 35961024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monocyte Chemotactic Protein-1, Fractalkine, and Receptor for Advanced Glycation End Products in Different Pathological Types of Lupus Nephritis and Their Value in Different Treatment Prognoses.
    Lan L; Han F; Lang X; Chen J
    PLoS One; 2016; 11(7):e0159964. PubMed ID: 27458981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature.
    Baranowska-Daca E; Choi YJ; Barrios R; Nassar G; Suki WN; Truong LD
    Hum Pathol; 2001 Oct; 32(10):1125-35. PubMed ID: 11679948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary clusterin-a novel urinary biomarker associated with pediatric lupus renal histopathologic features and renal survival.
    Wu CY; Yang HY; Chien HP; Tseng MH; Huang JL
    Pediatr Nephrol; 2018 Jul; 33(7):1189-1198. PubMed ID: 29511890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritis.
    Brunner HI; Bennett MR; Mina R; Suzuki M; Petri M; Kiani AN; Pendl J; Witte D; Ying J; Rovin BH; Devarajan P
    Arthritis Rheum; 2012 Aug; 64(8):2687-97. PubMed ID: 22328173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary Soluble CD163: a Novel Noninvasive Biomarker of Activity for Lupus Nephritis.
    Mejia-Vilet JM; Zhang XL; Cruz C; Cano-Verduzco ML; Shapiro JP; Nagaraja HN; Morales-Buenrostro LE; Rovin BH
    J Am Soc Nephrol; 2020 Jun; 31(6):1335-1347. PubMed ID: 32300067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The utility of urinary biomarker panel in predicting renal pathology and treatment response in Chinese lupus nephritis patients.
    Liu L; Wang R; Ding H; Tian L; Gao T; Bao C
    PLoS One; 2020; 15(10):e0240942. PubMed ID: 33108403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis.
    Romick-Rosendale LE; Brunner HI; Bennett MR; Mina R; Nelson S; Petri M; Kiani A; Devarajan P; Kennedy MA
    Arthritis Res Ther; 2011; 13(6):R199. PubMed ID: 22152586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative planar array screen of 1000 proteins uncovers novel urinary protein biomarkers of lupus nephritis.
    Vanarsa K; Soomro S; Zhang T; Strachan B; Pedroza C; Nidhi M; Cicalese P; Gidley C; Dasari S; Mohan S; Thai N; Truong VTT; Jordan N; Saxena R; Putterman C; Petri M; Mohan C
    Ann Rheum Dis; 2020 Oct; 79(10):1349-1361. PubMed ID: 32651195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.